VENTURA, Paolo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 18.316
EU - Europa 14.301
AS - Asia 7.466
SA - Sud America 1.189
AF - Africa 121
OC - Oceania 35
Continente sconosciuto - Info sul continente non disponibili 16
Totale 41.444
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 18.083
IT - Italia 4.979
GB - Regno Unito 4.779
CN - Cina 2.554
SG - Singapore 2.260
SE - Svezia 1.053
HK - Hong Kong 979
BR - Brasile 967
DE - Germania 789
UA - Ucraina 558
FI - Finlandia 434
FR - Francia 424
VN - Vietnam 423
TR - Turchia 379
RU - Federazione Russa 376
KR - Corea 239
NL - Olanda 230
BG - Bulgaria 172
IN - India 171
CA - Canada 137
ID - Indonesia 113
AR - Argentina 92
PL - Polonia 82
BE - Belgio 70
IE - Irlanda 64
JP - Giappone 62
MX - Messico 60
ZA - Sudafrica 56
ES - Italia 49
BD - Bangladesh 46
CH - Svizzera 37
EC - Ecuador 36
LT - Lituania 35
RO - Romania 35
IQ - Iraq 34
MY - Malesia 31
AT - Austria 29
AU - Australia 28
IR - Iran 23
VE - Venezuela 21
CZ - Repubblica Ceca 20
CO - Colombia 19
PE - Perù 18
MA - Marocco 16
PT - Portogallo 16
AE - Emirati Arabi Uniti 14
CL - Cile 14
UZ - Uzbekistan 14
AZ - Azerbaigian 13
NO - Norvegia 13
EU - Europa 12
IL - Israele 12
JO - Giordania 12
PH - Filippine 11
SA - Arabia Saudita 11
GR - Grecia 10
JM - Giamaica 10
PK - Pakistan 10
EG - Egitto 9
PY - Paraguay 8
AL - Albania 7
TH - Thailandia 7
TN - Tunisia 7
TT - Trinidad e Tobago 7
TW - Taiwan 7
BO - Bolivia 6
KE - Kenya 6
NP - Nepal 6
NZ - Nuova Zelanda 6
UY - Uruguay 6
HU - Ungheria 5
KG - Kirghizistan 5
DK - Danimarca 4
DZ - Algeria 4
GT - Guatemala 4
HR - Croazia 4
MK - Macedonia 4
PS - Palestinian Territory 4
RS - Serbia 4
BH - Bahrain 3
BN - Brunei Darussalam 3
BY - Bielorussia 3
DO - Repubblica Dominicana 3
HN - Honduras 3
LK - Sri Lanka 3
MD - Moldavia 3
NG - Nigeria 3
OM - Oman 3
PA - Panama 3
SM - San Marino 3
ZW - Zimbabwe 3
A2 - ???statistics.table.value.countryCode.A2??? 2
CR - Costa Rica 2
GA - Gabon 2
KZ - Kazakistan 2
LB - Libano 2
LV - Lettonia 2
MN - Mongolia 2
MT - Malta 2
MU - Mauritius 2
Totale 41.408
Salva come PNG Salva come JPEG
Città #
Southend 3.859
Santa Clara 1.860
Fairfield 1.791
Ashburn 1.601
Singapore 1.409
Chandler 1.194
Woodbridge 1.107
Houston 1.080
Hong Kong 971
Hefei 927
Jacksonville 818
Ann Arbor 621
Seattle 599
Wilmington 591
Dearborn 574
Cambridge 568
Nyköping 555
London 540
Beijing 436
Rome 362
San Jose 304
Los Angeles 279
Helsinki 272
Milan 263
Dallas 259
Chicago 245
Modena 239
Seoul 228
Izmir 196
San Diego 186
Princeton 181
Sofia 167
New York 160
Ho Chi Minh City 158
Eugene 150
Munich 147
The Dalles 144
Council Bluffs 116
Moscow 110
Shanghai 105
São Paulo 99
Bremen 89
Bologna 88
Hanoi 88
Buffalo 87
Jakarta 86
Salt Lake City 82
Des Moines 75
Naples 75
Parma 68
Columbus 66
Rimini 65
Phoenix 64
Brussels 63
Palermo 62
Redwood City 53
Florence 51
Warsaw 51
Yalova 50
Falls Church 49
Verona 49
Toronto 48
Dublin 45
Tokyo 44
Amsterdam 41
Catania 41
Bari 37
Fremont 37
Rio de Janeiro 37
Tampa 37
Montreal 36
Turin 36
Turku 35
Guangzhou 34
Johannesburg 32
Padova 32
Elk Grove Village 31
Frankfurt am Main 31
Stockholm 31
Poplar 30
Chennai 29
Kunming 29
Brooklyn 28
Denver 28
Mumbai 28
Orem 28
Boardman 26
Atlanta 25
Brasília 25
Genoa 25
Kent 25
Dong Ket 24
Norwalk 24
Reggio Emilia 24
San Mateo 24
Belo Horizonte 23
Messina 22
Miami 22
Sterling 22
Haiphong 21
Totale 28.029
Salva come PNG Salva come JPEG
Nome #
Effetti dell’insulina sui livelli di omocisteina plasmatica in pazienti con diabete mellito tipo ii con e senza intolleranza alla metionina 2.298
Weight Loss Expectations in Obese Patients and Treatment Attrition: An Observational Multicenter Study 660
Terapia antialadosteronica e prevenzione della cardiomiopatia cirrotica 652
Validating the Body Uneasiness Test (BUT) in obese patients 611
Trombosi portale e iperomocisteinemia in pazienti con cirrosi epatica 580
Impiego dei marcatori di neoplasia (CEA, CA 19.9, CA 125, CA 16.3, NSE) in Medinina Interna: uno studio retrospettivo 539
Isomeri urinari della Coproporfirina in pazienti con Epatopatie Colestatiche Acquisite e sindrome di Dubin-Johnson 520
The QUOVADIS Study: features of obese Italian patients seeking treatment at specialist centers 467
Alendronate reduces bone resorption in HIV-associated osteopenia/osteoporosis 458
Oxford Manuale di Medicina Clinica 444
Hyperhomocysteinaemia in chronic liver diseases: role of disease stage, vitamin status and methylenetetrahydrofolate reductase genetics 443
Serum Albumin Is Inversely Associated With Portal Vein Thrombosis in Cirrhosis 387
Clinical and molecular epidemiology of erythropoietic protoporphyria in Italy 368
Acute Intermittent Porphyria in a Child with Severe Neuropathy 356
A challenging diagnosis for potential fatal diseases: Recommendations for diagnosing acute porphyrias 348
EXPLORE: A Prospective, Multinational, Natural History Study of Patients with Acute Hepatic Porphyria with Recurrent Attacks 343
Clinical impact of application of risk assessment models (Padua Prediction Score and Improve Bleeding Score) on venous thromboembolism, major hemorrhage and health expenditure associated with pharmacologic VTE prophylaxis: a “real life” prospective and retrospective observational study on patients hospitalized in a Single Internal Medicine Unit (the STIME study) 342
The Acute Porphyric Attack: A Difficult Diagnosis for a Potential Lethal Event in Emergency Medicine 340
Safety and efficacy of sucrosomal iron in inflammatory bowel disease patients with iron deficiency anemia 327
Ceruloplasmin gene variants are associated with hyperferritinemia and increased liver iron in patients with {NAFLD} 314
MARKERS OF ENDOTHELIAL DYSFUNCTION AS PREDICTORS OF ASCITIC DECOMPENSATION IN PATIENTS WITH LIVER CIRRHOSIS. 306
A role for homocysteine increase in haemolysis of megaloblastic anaemias due to vitamin B-12 and folate deficiency: results from an in vitro experience 306
Rhodococcus equi Pneumonia in Kidney Transplant Recipient Affected by Acute Intermittent Porphyria: A Case Report 306
Weight Loss Expectations in Obese Patients Seeking Treatment at Medical Centers 302
IS FLOW-MEDIATED DILATATION (FMD) ASSESSMENT A RELIABLE MARKER OF ENDOTHELIAL DYSFUNCTION IN LIVER CIRRHOSIS? 301
Antiviral treatment profoundly affects iron status in HCV patients: Implications for management and treatment outcome 299
Hepcidin expression does not rescue the iron-poor phenotype of Kupffer cells in Hfe-null mice after liver transplantation. 297
Bone Morphogenetic Protein Signaling Is Impaired in an Hfe Knockout Mouse Model of Hemochromatosis. 294
Molecular characterization, by digital PCR analysis of four HMBS gene mutations affecting the ubiquitous isoform of Porphobilinogen Deaminase (PBGD) in patients with Acute Intermittent Porphyria (AIP) 290
ANTIALDOSTERONE THERAPY IN LIVER CIRRHOSIS: A ROLE FOR PREVENTION OF CIRROTHIC CARDIOMIOPATHY? 290
HYPERHOMOCYSTEINEMIA AND MTHFR C677T POLYMORPHISM IN PATIENTS WITH PORTAL VEIN THROMBOSIS COMPLICATING LIVER CIRRHOSIS 287
Serum and Liver Iron Differently Regulate the Bone Morphogenetic Protein 6 (BMP6)-SMAD Signaling Pathway in Mice 284
04093 Portal hypertension in advanced protoporphyric hepatopathy: a case report 281
04092 Liver function, iron status, and hemopoiesis in erythropoietic protoporphyria (EPP): insights into a complex interplay 279
Drugs and acute porphyrias: reasons for a hazardous relationship 277
Alendronate treatment for osteoporosis in patients infected with human immunodeficiency virus. 274
Hepatocellular Carcinoma in HIV-infected Patients: Check Ealy, Treat Hard 272
A large deletion on chromosome 11 in acute intermittent porphyria 271
Platelet count does not predict bleeding in cirrhotic patients: Results from the PRO-LIVER Study 267
Genetic polymorphisms of Fas (CD95) and FasL (CD178) in human longevity: studies on centenarians 260
Anti- and pro-oxidant factors and endothelial dysfunction in chronic cigarette smokers with coronary heart disease 260
N-acetyl-cysteine reduces homocysteine plasma levels after single intravenous administration by increasing thiols urinary excretion 257
The Metabolic Syndrome in Treatment-Seeking Obese Persons 256
Antialdosterone therapy in liver cirrhosis: a role for prevention of cirrhitc cardiomiopathy ? 255
Clinical, biochemical and genetic characteristics of Variegate Porphyria in Italy 254
Radiofrequency ablation combined with transcatheter arterial chemioembolization in the treatment of advanced hepatocellular carcinoma 254
Pathological fractures in AIDS patients with osteopenia and osteoporosis induced by antiretroviral therapy 253
Alendronate reduces bone turnover in HIV-associated Osteopenia and Osteoporosis 253
Weight cycling in treatment-seeking obese persons: data from the QUOVADIS study 250
Urinary coproporhyrin isomers during therapy with IFn-RIBA in patients with chronic hepatitis due to HCV infection 248
Hyperhomocysteinemia in patients with acute porphyrias: A potentially dangerous metabolic crossroad? 248
HIV INFECTION AND SURVIVAL IN PATIENTS WITH HCCAND LIVER CIRRHOSIS 245
Hyperhomocysteinaemia in HIV-infected patients: determinants of variability and correlations with predictors of cardiovascular disease. 243
Tumour markers in internal medicine: a low-cost test or an unnecessary expense? A retrospective study based on appropriateness 243
Role of Multidrug-Resistance Protein 2 in coproporphyrin transport: results from experimental studies in bile fistula rat models 241
Affinità dell'omocisteina per le lipoproteine 241
Prevalence Of Subclinical Liver Fibrosis Among Patients With Idiopathic Pulmonary Fibrosis 241
THE MOLECULAR BASIS FOR THE HEPATIC REGULATION OF HEPCIDIN, THE IRON HORMONE, BY BONE MORPHOGENETIC PROTEINS. 241
Psychological Distress in Morbid Obesity in Relation to Weight History 239
Pro-oxidant and antioxidant factors in acute intermittent porphyria: Family studies 238
MTHFR C677T polymorhism and hyperhomocysteinemia in patients with liver cirrhosis complicated by portal vein thrombosis and hepatocellular carcinoma 236
Red wine consumption prevents vascular oxidative stress induced by a high-fat meal in healthy volunteers 235
Prevention of a first episode of variceal bleeding: role of duplex Doppler sonographic measurement of the acute response to beta-blockers. 233
THE INTERACTION OF BILIAR ACIDS WITH 2-HYDROXYPROPYL-CYCLODEXTRIN IN SOLUTION AND IN THE SOLID STATE 230
Continuous combined hormone replacement therapy with oral 17β-estradiol and norethisterone acetate improves homocysteine metabolism in postmenopausal women 229
Serum ferritin as a predictor of treatment outcome in patients with chronic hepatitis C 227
Relevance of different apolipoprotein content in binding of homocysteine to plasma lipoproteins 226
EXPLORE: A prospective, multinational natural history study of acute hepatic porphyria patients with recurrent attacks 225
Challenges in diagnosis and management of acute hepatic porphyrias: from an uncommon pediatric onset to innovative treatments and perspectives 221
Parametri predittivi e risposta sostenuta alla terapia antivirale combinata nell'epatite cronica attivva HCV correlata (ECA HCV) 220
Hyperhomocysteinemia and related factors in 600 hospitalized elderly subjects 218
Impact of nutrition on cognition and affectivity in the elderly: A review 217
The Effect of Obesity Management on Body Image in Patients Seeking Treatment at Medical Centers 217
Clinical factors associated with death in 3044 COVID-19 patients managed in internal medicine wards in Italy: results from the SIMI-COVID-19 study of the Italian Society of Internal Medicine (SIMI) 216
Snoring, hypertension and Type 2 diabetes in obesity. Protection by physical activity 216
Construct Validity of the Short Form-36 Health Survey and Its Relationship with BMI in Obese Outpatients 215
Novel human pathological mutations. Gene symbol: PPOX. Disease: porphyria, variegate 215
Alendronate for the treatment of Osteoporosis in HIV-infected patients. 214
Studi preformulativi sul complesso di inclusione tra acido ursodesossicolico e beta-ciclodestrine 214
Correlation between plasma malonyldialdeide levels and paroxonase activity in healthy subjects and in patients with atherosclerotic disease 213
When awareness makes the difference: diagnosing and treating the acute hepatic porphyrias 213
Plasma nitric oxide production during acute hyperhomocysteinemia in atherosclerotic patients and controls 212
Flow-mediated dilatation (FMD) assessment as a marker of endothelial dysfunction in liver cirrhosis 210
Portal vein thrombosis and thrombophilia in liver cirrhosis: a role for hyperhomocysteinemia ? 210
Improvement of survival in patients with intermediate stage (BCLC-B) hepatocellular acrcinoma complicating liver cirrhosis by combination therapy with radiofrequency ablation and transcatheter chemioembolization 209
Serum endothelin-1 as predictor of ascitic decompensation in patients with liver cirrhosis 208
Peroxidation indices and total antioxidant capacity in plasma during hyperhomocysteinemia induced by methionine oral loading 205
Porfiria acuta intermittente: un caso "eccezionale" 205
Does the measurement of portal flow velocity have any value in the identification of patients with cirrhosis at risk of digestive bleeding ? 204
Insulin resistance in advanced liver cirrhosis : the role of liver dysfunction and the “dissociated” effect on glucose versus lipid and amino acid metabolism 202
Markers of Endothelial Dysfunction in patients with liver cirrhosis with anh without portal hypertension 200
Homocysteine Production and membrane oxidative stress in erythrocytes 198
Hepatocellular carcinoma in HIV infected patients: check early, treat hard. 198
Ursodeoxycholic acid complexation with 2-hydroxypropyl-beta-cyclodextrin increases ursodeoxycholic acid biliary excretion after single oral administration in rats 198
One- and two-dimensional NMR study of complexation of ursodeoxycholic acid with beta-cyclodextrin 195
Ataxia-myoclonus syndrome in patients with SARS-CoV2 infection 195
Clinical and psychological correlates of health related quality of life in obese patients 194
A Fatal Case of Pseudomonas aeruginosa Community-Acquired Pneumonia in an Immunocompetent Patient: Clinical and Molecular Characterization and Literature Review 194
Portal vein thrombosis relevance on liver cirrhosis: Italina Venous Thrombotic Events Registry 193
Sarcoma primitivo del cuore. Descrizione di un caso 193
Totale 29.973
Salva come PNG Salva come JPEG
Categoria #
all - tutte 146.930
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 146.930
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212.504 0 0 0 0 0 0 652 458 289 459 347 299
2021/20223.669 178 412 290 308 143 217 211 219 407 316 538 430
2022/20234.119 423 420 318 370 452 551 118 389 491 112 229 246
2023/20242.739 168 179 241 227 399 196 225 336 115 124 192 337
2024/20258.142 322 149 325 583 1.543 1.083 598 494 885 337 858 965
2025/20267.866 1.010 748 1.368 1.491 1.785 1.117 347 0 0 0 0 0
Totale 41.717